Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel ...Middle East

PR Newswire - News
Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel
The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, United Kingdom, April 3, 2023 /PRNewswire/ -- Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of...

Read More Details
Finally We wish PressBee provided you with enough information of ( Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel )

Apple Storegoogle play

Also on site :